Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January U.S. launch of the oral version of its ...
We independently select everything we recommend. Buying through us may earn us a commission, which supports our work. It’s no choke.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results